12.81
Citigroup Inc stock is traded at $12.81, with a volume of 1.50M.
It is down -0.27% in the last 24 hours and down -12.70% over the past month.
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
See More
Previous Close:
$12.85
Open:
$12.75
24h Volume:
1.50M
Relative Volume:
0.70
Market Cap:
$1.93B
Revenue:
$5.82B
Net Income/Loss:
$-411.00M
P/E Ratio:
-4.684
EPS:
-2.7359
Net Cash Flow:
$154.00M
1W Performance:
-7.34%
1M Performance:
-12.70%
6M Performance:
-44.36%
1Y Performance:
-11.13%
Citigroup Inc Stock (CC) Company Profile
Name
Citigroup Inc
Sector
Industry
Phone
302 773 1000
Address
1007 MARKET STREET, WILMINGTON, DE
Compare CC vs LIN, SHW, ECL, APD, PPG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CC
Citigroup Inc
|
12.81 | 1.93B | 5.82B | -411.00M | 154.00M | -2.7359 |
|
LIN
Linde Plc
|
494.68 | 228.04B | 34.66B | 7.25B | 5.10B | 15.07 |
|
SHW
Sherwin Williams Co
|
336.92 | 81.79B | 23.94B | 2.60B | 2.91B | 10.42 |
|
ECL
Ecolab Inc
|
291.56 | 81.73B | 16.45B | 2.12B | 1.87B | 7.3955 |
|
APD
Air Products Chemicals Inc
|
295.10 | 65.71B | 12.46B | 2.16B | -1.25B | 9.454 |
|
PPG
Procter Gamble Co
|
107.92 | 23.99B | 16.12B | 1.59B | 1.23B | 6.9799 |
Citigroup Inc Stock (CC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-26 | Initiated | Barclays | Equal Weight |
| Oct-13-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Aug-10-26 | Downgrade | UBS | Buy → Neutral |
| Mar-27-25 | Upgrade | Mizuho | Neutral → Outperform |
| Jan-28-25 | Initiated | Truist | Buy |
| Jul-09-24 | Upgrade | UBS | Neutral → Buy |
| Jun-07-24 | Initiated | Mizuho | Neutral |
| Apr-09-24 | Upgrade | BMO Capital Markets | Underperform → Outperform |
| Mar-05-24 | Downgrade | UBS | Buy → Neutral |
| Feb-29-24 | Downgrade | BMO Capital Markets | Outperform → Underperform |
| Dec-01-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jun-22-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-23 | Upgrade | UBS | Neutral → Buy |
| Jan-11-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-10-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-01-22 | Initiated | Credit Suisse | Underperform |
| Oct-13-22 | Initiated | Goldman | Neutral |
| Oct-05-22 | Downgrade | Argus | Buy → Hold |
| Jun-14-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-10-21 | Initiated | Wolfe Research | Outperform |
| Jun-09-21 | Upgrade | Goldman | Neutral → Buy |
| May-20-21 | Initiated | BofA Securities | Buy |
| May-06-21 | Upgrade | Argus | Hold → Buy |
| Jan-08-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Dec-04-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Nov-30-20 | Initiated | Alembic Global Advisors | Overweight |
| Mar-23-20 | Downgrade | Jefferies | Buy → Hold |
| Feb-14-20 | Upgrade | CFRA | Buy → Strong Buy |
| Nov-06-19 | Upgrade | CFRA | Hold → Buy |
| Aug-20-19 | Upgrade | Susquehanna | Neutral → Positive |
| Aug-09-19 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Aug-06-19 | Downgrade | Argus | Buy → Hold |
| Aug-05-19 | Downgrade | SunTrust | Buy → Hold |
| Jul-12-19 | Downgrade | Citigroup | Buy → Neutral |
| May-06-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-15-19 | Upgrade | SunTrust | Hold → Buy |
| Feb-19-19 | Downgrade | Susquehanna | Positive → Neutral |
| Jan-08-19 | Initiated | HSBC Securities | Buy |
| Jan-04-19 | Upgrade | Citigroup | Neutral → Buy |
| Nov-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jul-18-18 | Initiated | RBC Capital Mkts | Outperform |
| Jan-30-18 | Initiated | Morgan Stanley | Equal-Weight |
| Dec-06-17 | Downgrade | Goldman | Buy → Neutral |
| Aug-07-17 | Upgrade | UBS | Sell → Neutral |
View All
Citigroup Inc Stock (CC) Latest News
Bronstein, Gewirtz & Grossman LLC Urges Chemours Company Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Chemours stock gains 1.20 percent as UBS cuts target - AD HOC NEWS
UBS Adjusts Chemours Price Target to $16 From $18, Maintains Neutral Rating - marketscreener.com
Chemours Company (The) (CC) Stock Forecasts - Yahoo! Finance Canada
Environmentalists say Chemours not doing enough to reduce PFAS discharges - Wilmington Star-News
Chemours backs longer refrigerant transition: what it means for Chemours stock - AD HOC NEWS
Corporations Are Dodging Accountability for PFAS Contamination Around the Globe - truthout.org
Chemours Company (The) (CC) Stock Forecasts - Yahoo! Finance Canada
Form 4 Chemours Co For: 2 October By Investing.com - Investing.com South Africa
Form 4 Chemours Co For: 2 October By Investing.com - Investing.com UK
Chemours Company (The) (CC) Stock Forecasts - Yahoo Finance
Chemours Company (The) (CC) Stock Forecasts - Yahoo Finance
Cape Fear River Watch vows to hold Chemours accountable - Coastal Review
2CU Stock Price and Chart — HAN:2CU - TradingView
Are Options Traders Betting on a Big Move in Chemours Stock? - Zacks Investment Research
Are Options Traders Betting on a Big Move in Chemours Stock? - TradingView
Are Options Traders Betting on a Big Move in Chemours Stock? - Yahoo Finance
Chemours Supports Automotive Industry's Ask to Extend Fluorinated Refrigerant Transition for EU Mobile Air Conditioning Beyond 2040 - PR Newswire
Sunday Edition: Editor’s Notes on Chemours, Flock Camers, and the Cape Fear Memorial Bridge - WHQR
CF River Watch says Chemours broke consent order; company disputes claim - Port City Daily
A Look at The Chemours Co (CC) After 3.7% Decline -- GF Value $1 - gurufocus.com
Notice letter: PFAS pollution from Chemours facility violates consent order - WECT
Chemours still leaking ‘forever chemicals,’ violating NC court order, group says - News & Observer
Environmental groups allege Chemours hasn't met PFAS limits agreement - wunc.org
Chemours must cut back on PFAS discharge. Wood County residents say the damage is already done. - Mountain State Spotlight
Corient Private Wealth LP Sells 62,908 Shares of Citigroup Inc. $C - MarketBeat
Citi Adjusts Fed Rate Outlook: Rate Hike in September, Cuts by M - GuruFocus
Citigroup Inc. stock holds steady as investors eye new senior notes offering - ad-hoc-news.de
Cuba property claims complicate rival bids for Canadian miner Sherritt - Mining.com
Citi reiterates 0-3 month copper price view at $15,000/t - marketscreener.com
DRI Maintained by Citigroup -- Price Target Raised to $248 - GuruFocus
Citigroup Issues Positive Forecast for Darden Restaurants (NYSE:DRI) Stock Price - MarketBeat
Citigroup Issues Pessimistic Forecast for Clorox (NYSE:CLX) Stock Price - MarketBeat
Why is Citigroup (NYSE:C) stock in focus today? - Kalkine Media
Oklo Launches $1 Billion ATM Equity Program With Goldman Sachs, BofA, Citi and Others - TradingView
Citi and Office Depot Have a ‘Veto’ Over Who Buys a Troubled Cuba Miner - Bloomberg.com
Citigroup Inc. $C Shares Sold by The Manufacturers Life Insurance Company - MarketBeat
Citigroup to Launch Blockchain-Based Cross-Border Payments for Japanese Companies - Global Cosmetics News
Citigroup stock heads into the open after a 0.8 percent gain - ad-hoc-news.de
Citigroup (C) Completed a Weekend Tokenized-Dollar Transfer. Can the Network Scale? - finance.yahoo.com
SIG Maintained by Citigroup -- Price Target Raised to $140 - GuruFocus
Sana Biotechnology at citigroup’s biopharma back to school summit 2026: diabetes push - Investing.com
BioMarin at Citi summit: voxzogo drives growth as pipeline widens By Investing.com - Investing.com Canada
SYK Maintained by Citigroup -- Price Target Lowered to $360 - GuruFocus
Transcript : Novavax, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-10-2026 10:00 AM - marketscreener.com
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc. - StreetInsider
Citigroup Lowers York Space Systems (NYSE:YSS) Price Target to $13.00 - MarketBeat
Kymera Therapeutics at citigroup summit: oral immunology push gains pace By Investing.com - Investing.com India
SAB BIO at Citi summit: trial progress and a bigger t1d bet - Investing.com India
SAB BIO at Citi summit: trial progress and a bigger t1d bet - Investing.com UK
Citigroup Inc Stock (CC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Citigroup Inc Stock (CC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dignam Denise | Chief Executive Officer |
Aug 11 '26 |
Buy |
14.95 |
3,378 |
50,501 |
339,916 |
| Cowan Alister | Director |
Aug 07 '26 |
Buy |
15.62 |
13,000 |
203,060 |
56,988 |
| CRANSTON MARY B | Director |
Aug 07 '26 |
Buy |
15.82 |
6,000 |
94,950 |
113,141 |
| Martinko Joseph T. | See Remarks |
Aug 07 '26 |
Buy |
15.47 |
1,940 |
30,009 |
55,431 |
| HOSTETTER SHANE | Chief Financial Officer |
Aug 06 '26 |
Buy |
14.94 |
3,350 |
50,049 |
102,698 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):